AMNEAL PHARMACEUTICALS, INC Gross Profit 2010-2025 | AMRX

AMNEAL PHARMACEUTICALS, INC gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
AMNEAL PHARMACEUTICALS, INC Annual Gross Profit
(Millions of US $)
2024 $1,020
2023 $821
2022 $785
2021 $769
2020 $628
2019 $353
2018 $716
2017 $526
2016 $597
2015 $352
2014 $313
2013 $199
2012 $283
2011 $258
2010 $539
2009 $188
AMNEAL PHARMACEUTICALS, INC Quarterly Gross Profit
(Millions of US $)
2025-03-31 $256
2024-12-31 $263
2024-09-30 $270
2024-06-30 $250
2024-03-31 $238
2023-12-31 $190
2023-09-30 $233
2023-06-30 $220
2023-03-31 $178
2022-12-31 $215
2022-09-30 $194
2022-06-30 $201
2022-03-31 $175
2021-12-31 $166
2021-09-30 $199
2021-06-30 $212
2021-03-31 $192
2020-12-31 $167
2020-09-30 $134
2020-06-30 $144
2020-03-31 $183
2019-12-31 $110
2019-09-30 $54
2019-06-30 $105
2019-03-31 $83
2018-12-31 $193
2018-09-30 $200
2018-06-30 $178
2018-03-31 $145
2017-12-31 $243
2017-09-30 $135
2017-06-30 $124
2017-03-31 $25
2016-12-31 $587
2016-09-30 $-165
2016-06-30 $73
2016-03-31 $103
2015-12-31 $115
2015-09-30 $94
2015-06-30 $85
2015-03-31 $59
2014-12-31 $61
2014-09-30 $84
2014-06-30 $110
2014-03-31 $58
2013-12-31 $34
2013-09-30 $48
2013-06-30 $59
2013-03-31 $58
2012-12-31 $64
2012-09-30 $78
2012-06-30 $78
2012-03-31 $63
2011-12-31 $77
2011-09-30 $63
2011-06-30 $60
2011-03-31 $59
2010-12-31 $50
2010-09-30 $161
2010-06-30 $84
2010-03-31 $244
2009-12-31 $87
2009-09-30 $37
2009-06-30 $31
2009-03-31 $33
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.351B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.021B 32.64
Zoetis (ZTS) United States $72.987B 27.23
Daiichi Sankyo, - (DSNKY) Japan $49.540B 25.20
Takeda Pharmaceutical (TAK) Japan $45.278B 9.01
Sandoz Group AG (SDZNY) Switzerland $20.747B 0.00
Summit Therapeutics (SMMT) United States $17.831B 0.00
Merck (MKKGY) Germany $16.820B 12.32
United Therapeutics (UTHR) United States $13.772B 12.18
Shionogi (SGIOY) Japan $13.084B 13.11
Neurocrine Biosciences (NBIX) United States $12.155B 41.63
IPSEN (IPSEY) France $9.731B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $7.934B 64.50
Stevanato Group S.p.A (STVN) Italy $7.504B 45.89
Madrigal Pharmaceuticals (MDGL) United States $6.455B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.500B 0.00
Ionis Pharmaceuticals (IONS) United States $5.416B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.809B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.004B 10.53
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 18.12
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.090B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.833B 0.00
Guardian Pharmacy Services (GRDN) United States $1.678B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Indivior (INDV) United States $1.610B 6.83
Evotec AG (EVO) Germany $1.410B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.325B 0.00
Ocular Therapeutix (OCUL) United States $1.196B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.090B 21.81
Harrow (HROW) United States $1.038B 0.00
Ardelyx (ARDX) United States $0.971B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.17
Avadel Pharmaceuticals (AVDL) Ireland $0.905B 0.00
Enliven Therapeutics (ELVN) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.762B 0.00
Akebia Therapeutics (AKBA) United States $0.735B 0.00
AleAnna (ANNA) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.600B 0.00
Xencor (XNCR) United States $0.574B 0.00
Bioventus (BVS) United States $0.569B 14.44
USANA Health Sciences (USNA) United States $0.560B 12.17
Elite Pharmaceuticals (ELTP) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Savara (SVRA) United States $0.541B 0.00
Relay Therapeutics (RLAY) United States $0.502B 0.00
Zevra Therapeutics (ZVRA) United States $0.487B 0.00
CytoDyn (CYDY) United States $0.481B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.470B 0.00
Altimmune (ALT) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.433B 9.05
Tourmaline Bio (TRML) United States $0.427B 0.00
Organogenesis (ORGO) United States $0.410B 0.00
Verve Therapeutics (VERV) United States $0.390B 0.00
Oruka Therapeutics (ORKA) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.352B 9.52
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.22
Aquestive Therapeutics (AQST) United States $0.243B 0.00
ProKidney (PROK) United States $0.237B 0.00
MediWound (MDWD) Israel $0.222B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.195B 0.00
Wellgistics Health (WGRX) United States $0.193B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Avita Medical (RCEL) United States $0.178B 0.00
4D Molecular Therapeutics (FDMT) United States $0.176B 0.00
Esperion Therapeutics (ESPR) United States $0.171B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Journey Medical (DERM) United States $0.156B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
Aldeyra Therapeutics (ALDX) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Larimar Therapeutics (LRMR) United States $0.125B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
VAXART, INC (VXRT) United States $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.098B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Cumberland Pharmaceuticals (CPIX) United States $0.082B 60.56
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Surrozen (SRZN) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Mannatech (MTEX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00